Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by smartbroker12on Dec 18, 2017 7:58pm
188 Views
Post# 27183174

Cannabis License

Cannabis LicenseJust patiently waiting for VRX Cannabis license news. I don't think CEO is a fool who don't attempt to buy existing business or venture into the Cannabis industry to pay off its debt and increase source of revenue. 
Looks like VRX is releasing information in batches to boost shareprice gradually. Big sharks must have insider information about it thats why JP Morgan scared the bullish investors to buy shares at $24 instead of $28.30. In two days they made atleast 3 dollars profit per share instead of buying at $32 or $35 after news. 
<< Previous
Bullboard Posts
Next >>